Assertio Stock Gains Amid Clash With Activist Investor, Q3 Earnings

Seeking AlphaNov 12 06:49

UBS Upgrades Teva Pharmaceutical Industries(TEVA.US) to Buy Rating, Maintains Target Price $26

Futu NewsNov 11 17:33 · Ratings

Teva to Present at the Jefferies London Healthcare Conference

GlobeNewswireNov 9 05:30

Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now?

Yahoo FinanceNov 8 22:40

UBS Downgrades Teva Pharmaceutical Industries(TEVA.US) to Hold Rating, Maintains Target Price $26

Futu NewsNov 8 21:32 · Ratings

BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $23

Futu NewsNov 7 20:31 · Ratings